Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,171 GBX | -0.01% | -1.43% | +14.68% |
11:28am | AstraZeneca trials yield positive results for immunocompromised patients | AN |
11:23am | AstraZeneca: positive results in Covid prevention | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.68% | 239B | |
+35.01% | 709B | |
+31.16% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+9.40% | 211B | |
-4.13% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Says US FDA Approves Fasenra to Treat Children Aged 6 to 11 With Severe Asthma